MXPA05011830A - Peptidos para uso en el tratamiento de la obesidad. - Google Patents

Peptidos para uso en el tratamiento de la obesidad.

Info

Publication number
MXPA05011830A
MXPA05011830A MXPA05011830A MXPA05011830A MXPA05011830A MX PA05011830 A MXPA05011830 A MX PA05011830A MX PA05011830 A MXPA05011830 A MX PA05011830A MX PA05011830 A MXPA05011830 A MX PA05011830A MX PA05011830 A MXPA05011830 A MX PA05011830A
Authority
MX
Mexico
Prior art keywords
peptides
treating obesity
obesity
useful
formula
Prior art date
Application number
MXPA05011830A
Other languages
English (en)
Inventor
Ingrid Vivika Petterson
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority claimed from PCT/DK2004/000308 external-priority patent/WO2004099246A2/en
Publication of MXPA05011830A publication Critical patent/MXPA05011830A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Se proporcionan peptidos ciclicos y lineales novedosos de la formula R1-X-X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11-R2 que son utiles en el tratamiento de la obesidad.
MXPA05011830A 2003-05-09 2004-05-05 Peptidos para uso en el tratamiento de la obesidad. MXPA05011830A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200300706 2003-05-09
US47063903P 2003-05-15 2003-05-15
DKPA200400172 2004-02-05
US54396204P 2004-02-12 2004-02-12
PCT/DK2004/000308 WO2004099246A2 (en) 2003-05-09 2004-05-05 Peptides for use in treating obesity

Publications (1)

Publication Number Publication Date
MXPA05011830A true MXPA05011830A (es) 2006-01-26

Family

ID=33437115

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011830A MXPA05011830A (es) 2003-05-09 2004-05-05 Peptidos para uso en el tratamiento de la obesidad.

Country Status (5)

Country Link
US (1) US7541430B2 (es)
KR (1) KR20060026011A (es)
MX (1) MXPA05011830A (es)
NO (1) NO20055820L (es)
ZA (1) ZA200508063B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1809666A2 (en) * 2004-11-04 2007-07-25 Novo Nordisk A/S Peptides for use in the treating obesity
CN103784937B (zh) 2005-09-16 2017-04-26 科内尔研究基金会 用于减少cd36表达的方法
CA2704651C (en) 2007-11-05 2017-03-07 Ipsen Pharma S.A.S. Use of melanocortins to treat insulin sensitivity
TW201002340A (en) * 2008-06-09 2010-01-16 Palatin Technologies Inc Melanocortin receptor-specific peptides for treatment of obesity
EP2300036B1 (en) 2008-06-09 2017-04-05 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
JP4864064B2 (ja) * 2008-10-30 2012-01-25 エムジーファーマ株式会社 抗糖尿病作用を有するペプチドおよびその用途
US20110184229A1 (en) * 2009-05-01 2011-07-28 Allergan, Inc. Laparoscopic gastric band with active agents
EP2424583A2 (en) * 2009-05-01 2012-03-07 Allergan, Inc. Laparoscopic gastric band with active agents
CA2761607C (en) 2009-06-08 2018-09-04 Yi-Qun Shi Melanocortin receptor-specific peptides
UY32690A (es) * 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
EP2440572B1 (en) 2009-06-08 2017-04-05 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
WO2011063367A1 (en) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Melanocortin-1 receptor-specific linear peptides
AU2010321738B2 (en) 2009-11-23 2016-07-14 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049547A (en) * 1988-02-11 1991-09-17 University Patents, Inc. Composition for stimulating integumental melanocytes
PT697891E (pt) * 1993-05-05 2000-09-29 Keith Rose Compostos de polioximas e sua preparacao
US5731408A (en) 1995-04-10 1998-03-24 Arizona Board Of Regents On Behalf Of The University Of Arizona Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
AU5348098A (en) 1996-12-17 1998-07-15 Quadrant Holdings Cambridge Limited Melanocortins
DE60126624T2 (de) 2000-08-30 2007-11-22 F. Hoffmann-La Roche Ag Zyklische peptide als agonisten für den melanocortin-4-rezeptor
ES2278016T3 (es) 2001-04-09 2007-08-01 Novartis Vaccines And Diagnostics, Inc. Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
CA2453515A1 (en) 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
WO2003006604A2 (en) 2001-07-12 2003-01-23 Merck & Co., Inc. Cyclic peptides as potent and selective melanocortin-4 receptor agonists
WO2003007949A1 (en) 2001-07-18 2003-01-30 Merck & Co., Inc. Bridged piperidine derivatives as melanocortin receptor agonists
US7115607B2 (en) 2001-07-25 2006-10-03 Amgen Inc. Substituted piperazinyl amides and methods of use
US7034004B2 (en) * 2002-05-07 2006-04-25 University Of Florida Peptides and methods for the control of obesity

Also Published As

Publication number Publication date
ZA200508063B (en) 2006-12-27
US20070244054A1 (en) 2007-10-18
US7541430B2 (en) 2009-06-02
NO20055820L (no) 2006-02-08
NO20055820D0 (no) 2005-12-08
KR20060026011A (ko) 2006-03-22

Similar Documents

Publication Publication Date Title
WO2004099246A3 (en) Peptides for use in treating obesity
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
TW200630367A (en) Substituted adenines and the uses thereof
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
TW200612918A (en) Lonidamine analogs
SG135176A1 (en) Modified human four helical bundle polypeptides and their uses
HK1095749A1 (en) Novel use of peptide compounds for in production of pharmacenticals for treating central neuropathic pain
SG165353A1 (en) Improved human interferon molecules and their uses
MY138285A (en) Fab i inhibitors
MXPA05012421A (es) Tratamiento sinergistico de cancer usando inmunomeros junto con agentes quimioterapeuticos.
ATE461217T1 (de) Glp-1-verbindungen
TNSN06022A1 (en) Use of calcitonin in osteoarthritis
NO20055741D0 (no) Nye kjemiske forbindelser
MXPA05011830A (es) Peptidos para uso en el tratamiento de la obesidad.
TW200716088A (en) Formulations and methods for treating amyloidosis
NO20054668L (no) Aplidin for multippelt myelom-behandling
IL177169A0 (en) Use of n- (2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
NO20053903D0 (no) Nukleotidlipidesterderivater.
SE0302304D0 (sv) Novel compounds
TW200510398A (en) Novel compounds
EP1659169A4 (en) DEVICE FOR TREATING CULTURES AND AUTOCULTIVATION DEVICE
UA85676C2 (en) Carbonyl compounds
PL371524A1 (en) Combination therapy for the treatment of bacterial infections
AU309683S (en) Massaging belt
MX2008001548A (es) Compuestos antitumorales.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal